Comprehensive Assessment in a Longitudinal Study on Young Men Who Have Sex With Men Attracting to chemseX
NCT ID: NCT05559658
Last Updated: 2024-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2023-02-20
2027-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Phase I of the study will be a cross-sectional descriptive study using a mixed methods data collection (focusing on qualitative data collection) to acquire information necessary for developing a more extensive study on the same matter.
Phase II of the study will be a prospective cohort study using a quantitative data collection.
Findings from phase I will guide the development of phase II which consist of a larger number of YMSM, important baseline and follow-up questionnaires and comorbidities assessments, sexually transmitted infections testing, and integration to care.
This protocol exclusively addresses the phase I of the study.
Once the phase I findings are finalized, the principal investigator will submit the phase II to the IRB of the Faculty of Medicine, Chulalongkorn University.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
A: Current chemsex users Men who have sex with men, Aged 16-35 years, Able to communicate in Thai fluently, Current chemsex users.
B: Former chemsex users (discontinued ≥90 days) Men who have sex with men, Aged 16-35 years, Able to communicate in Thai fluently, Former chemsex users (discontinued ≥90 days).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Men who have sex with men
2. Aged 16-35 years
3. Able to communicate in Thai fluently
4. Current chemsex users
5. Provide informed consent
Group 1B: Former chemsex users (discontinued ≥90 days)
1. Men who have sex with men
2. Aged 16-35 years
3. Able to communicate in Thai fluently
4. Former chemsex users (discontinued ≥90 days)
5. Provide informed consent
16 Years
35 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
amfAR, The Foundation for AIDS Research
OTHER
Institute of HIV Research and Innovation Foundation, Thailand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of HIV Research and Innovation
Pathum Wan, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nittaya Phanuphak, MD.,Ph.D.
Role: primary
Napasawan Chinlaertworasiri
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IHRI021
Identifier Type: -
Identifier Source: org_study_id